MIRM logo

Mirum Pharmaceuticals, Inc. (MIRM) EBIT

annual EBIT:

-$87.61M+$21.55M(+19.74%)
December 31, 2024

Summary

  • As of today (September 14, 2025), MIRM annual earnings before interest & taxes is -$87.61 million, with the most recent change of +$21.55 million (+19.74%) on December 31, 2024.
  • During the last 3 years, MIRM annual EBIT has risen by +$85.81 million (+49.48%).
  • MIRM annual EBIT is now -2904.32% below its all-time high of -$2.92 million, reached on December 31, 2018.

Performance

MIRM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMIRMincome statement metrics

quarterly EBIT:

-$1.87M+$8.18M(+81.40%)
June 30, 2025

Summary

  • As of today (September 14, 2025), MIRM quarterly earnings before interest & taxes is -$1.87 million, with the most recent change of +$8.18 million (+81.40%) on June 30, 2025.
  • Over the past year, MIRM quarterly EBIT has increased by +$18.56 million (+90.85%).
  • MIRM quarterly EBIT is now -103.05% below its all-time high of $61.32 million, reached on December 31, 2021.

Performance

MIRM quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMIRMincome statement metrics

TTM EBIT:

-$43.01M+$18.56M(+30.15%)
June 30, 2025

Summary

  • As of today (September 14, 2025), MIRM TTM earnings before interest & taxes is -$43.01 million, with the most recent change of +$18.56 million (+30.15%) on June 30, 2025.
  • Over the past year, MIRM TTM EBIT has increased by +$50.14 million (+53.83%).
  • MIRM TTM EBIT is now -66070.77% below its all-time high of -$65.00 thousand, reached on September 30, 2018.

Performance

MIRM TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMIRMincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

MIRM EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+19.7%+90.8%+53.8%
3 y3 years+49.5%+93.7%-1.1%
5 y5 years-60.0%+92.0%+44.0%

MIRM EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+49.5%at high+97.3%-31.0%+73.0%
5 y5-year-60.0%+49.5%-103.0%+97.3%-31.0%+73.9%
alltimeall time-2904.3%+49.5%-103.0%+97.3%<-9999.0%+73.9%

MIRM EBIT History

DateAnnualQuarterlyTTM
Jun 2025
-
-$1.87M(-81.4%)
-$43.01M(-30.1%)
Mar 2025
-
-$10.05M(-51.6%)
-$61.58M(-15.2%)
Dec 2024
-$87.61M(-19.7%)
-$20.79M(+101.8%)
-$72.60M(-13.2%)
Sep 2024
-
-$10.30M(-49.6%)
-$83.69M(-10.2%)
Jun 2024
-
-$20.43M(-3.1%)
-$93.15M(-34.7%)
Mar 2024
-
-$21.08M(-33.9%)
-$142.71M(-3.1%)
Dec 2023
-$109.15M(-16.8%)
-$31.87M(+61.2%)
-$147.32M(-0.0%)
Sep 2023
-
-$19.77M(-71.8%)
-$147.38M(-7.5%)
Jun 2023
-
-$70.00M(+172.5%)
-$159.34M(+33.9%)
Mar 2023
-
-$25.69M(-19.6%)
-$118.96M(-5.7%)
Dec 2022
-$131.22M(-24.3%)
-$31.93M(+0.7%)
-$126.09M(+284.0%)
Sep 2022
-
-$31.72M(+7.1%)
-$32.84M(-22.8%)
Jun 2022
-
-$29.62M(-9.8%)
-$42.55M(-18.2%)
Mar 2022
-
-$32.82M(-153.5%)
-$52.04M(-21.6%)
DateAnnualQuarterlyTTM
Dec 2021
-$173.41M(+66.3%)
$61.32M(-248.0%)
-$66.36M(-59.7%)
Sep 2021
-
-$41.43M(+5.9%)
-$164.55M(+13.8%)
Jun 2021
-
-$39.11M(-17.1%)
-$144.63M(+12.3%)
Mar 2021
-
-$47.15M(+27.9%)
-$128.77M(+25.1%)
Dec 2020
-$104.30M(+90.5%)
-$36.87M(+71.4%)
-$102.93M(+24.7%)
Sep 2020
-
-$21.51M(-7.5%)
-$82.51M(+7.3%)
Jun 2020
-
-$23.25M(+9.1%)
-$76.87M(+13.6%)
Mar 2020
-
-$21.31M(+29.5%)
-$67.65M(+28.8%)
Dec 2019
-$54.74M(+1777.3%)
-$16.45M(+3.7%)
-$52.53M(+45.6%)
Sep 2019
-
-$15.87M(+13.1%)
-$36.09M(+77.9%)
Jun 2019
-
-$14.03M(+126.9%)
-$20.28M(+224.6%)
Mar 2019
-
-$6.18M(+9413.8%)
-$6.25M(+9513.8%)
Dec 2018
-$2.92M
-
-
Sep 2018
-
-$65.00K
-$65.00K

FAQ

  • What is Mirum Pharmaceuticals, Inc. annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Mirum Pharmaceuticals, Inc.?
  • What is Mirum Pharmaceuticals, Inc. annual EBIT year-on-year change?
  • What is Mirum Pharmaceuticals, Inc. quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Mirum Pharmaceuticals, Inc.?
  • What is Mirum Pharmaceuticals, Inc. quarterly EBIT year-on-year change?
  • What is Mirum Pharmaceuticals, Inc. TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Mirum Pharmaceuticals, Inc.?
  • What is Mirum Pharmaceuticals, Inc. TTM EBIT year-on-year change?

What is Mirum Pharmaceuticals, Inc. annual earnings before interest & taxes?

The current annual EBIT of MIRM is -$87.61M

What is the all time high annual EBIT for Mirum Pharmaceuticals, Inc.?

Mirum Pharmaceuticals, Inc. all-time high annual earnings before interest & taxes is -$2.92M

What is Mirum Pharmaceuticals, Inc. annual EBIT year-on-year change?

Over the past year, MIRM annual earnings before interest & taxes has changed by +$21.55M (+19.74%)

What is Mirum Pharmaceuticals, Inc. quarterly earnings before interest & taxes?

The current quarterly EBIT of MIRM is -$1.87M

What is the all time high quarterly EBIT for Mirum Pharmaceuticals, Inc.?

Mirum Pharmaceuticals, Inc. all-time high quarterly earnings before interest & taxes is $61.32M

What is Mirum Pharmaceuticals, Inc. quarterly EBIT year-on-year change?

Over the past year, MIRM quarterly earnings before interest & taxes has changed by +$18.56M (+90.85%)

What is Mirum Pharmaceuticals, Inc. TTM earnings before interest & taxes?

The current TTM EBIT of MIRM is -$43.01M

What is the all time high TTM EBIT for Mirum Pharmaceuticals, Inc.?

Mirum Pharmaceuticals, Inc. all-time high TTM earnings before interest & taxes is -$65.00K

What is Mirum Pharmaceuticals, Inc. TTM EBIT year-on-year change?

Over the past year, MIRM TTM earnings before interest & taxes has changed by +$50.14M (+53.83%)
On this page